Research Article

Inhibition of Advanced Glycation End-Product Formation by Origanum majorana L. In Vitro and in Streptozotocin-Induced Diabetic Rats

Table 2

The inhibitory effects of methanol extract of O. majorana on glycosylated protein glycated, hemoglobin GHb and HbA1c.

Groups
GHb
HbA1c
Glycated protein (nmol/mg protein)

Negative control 8 . 9 ± 0 . 0 6 7.9 ± 0.98 1 5 . 3 ± 1 . 4 7
Positive control 2 7 . 6 ± 1 . 3 4 17.5 ± 1.56 2 3 . 7 ± 2 . 1 9
Methanol extract18.6 ± 1.53a14.9 ± 1.25a19.1 ± 2.04a
Glutathione8.1 ± 0.08a9.0 ± 0.67a
Aminoguanidine20.2 ± 1.87a

Negative control: incubation with hemoglobin (30 mg/mL), positive control: incubation with hemoglobin (30 mg/mL) + glucose (0.278 mM), methanol extract: incubation with hemoglobin (30 mg/dL) + glucose (0.278 mM) + methanol extract (10 mg/ mL), glutathione: incubation with hemoglobin (3 mg/dL) + glucose (2.7 mM) + glutathione (0.5 mM). Data as expressed as ± SD; a 𝑃 < 0 . 0 5 versus positive control values.